Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q1 2023 vs. Q4 2022
How the institutions holding Mesoblast Ltd changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 42 | 44 | +2 |
| Shares | 2.68M | 2.47M | −210.4K (−7.8%) |
| Value | $7.89M | $7.97M | +$85.6K (+1.1%) |
New holders (8)
Institutions that held Mesoblast Ltd at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 230,000 | $756.7K | 0.00% |
| Dynamic Technology Lab Private Ltd | 17,016 | $56.0K | 0.01% |
| Deltec Asset Management LLC | 16,308 | $53.7K | 0.01% |
| JustInvest LLC | 12,524 | $41.2K | 0.00% |
| Ewa, LLC | 11,030 | $40.1K | 0.03% |
| Aries Wealth Management | 10,000 | $32.9K | 0.01% |
| US Bancorp | 1,254 | $4.13K | 0.00% |
| Parallel Advisors, LLC | 190 | $625 | 0.00% |
Sold out (6)
Institutions that held Mesoblast Ltd at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Jane Street Group, LLC | 62,965 | $186.7K |
| Old Mission Capital LLC | 49,952 | $145.4K |
| Goldman Sachs Group Inc | 36,408 | $105.9K |
| Marshall Wace, LLP | 29,173 | $84.9K |
| Envestnet Asset Management Inc | 26,008 | $75.7K |
| Tower Research Capital LLC (TRC) | 2,582 | $8.00K |